These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17584825)

  • 21. A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).
    Yoshikawa T; Tsuburaya A; Morita S; Kodera Y; Ito S; Cho H; Miyashita Y; Sakamoto J
    Jpn J Clin Oncol; 2010 Apr; 40(4):369-72. PubMed ID: 20299499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
    Ajani JA
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
    Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
    Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
    Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
    Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
    Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kawabata R; Fujiwara Y; Doki Y; Fujita J; Tsukahara Y; Yamasaki M; Miyata H; Takiguchi S; Monden M
    Oncology; 2007; 72(3-4):219-25. PubMed ID: 18176087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
    Naito M; Shinohara T; Ishii F; Shibata R; Yamaguchi R; Maki K; Hoshino S; Tanaka S; Yamashita Y
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1553-6. PubMed ID: 19755832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
    Ilson D
    J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
    [No Abstract]   [Full Text] [Related]  

  • 30. [Two cases of advanced and recurrent gastric cancer treated with the combination of chemotherapy and radiation].
    Fujiwara Y; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1876-8. PubMed ID: 15553745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
    Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
    Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer].
    Gotoh M; Kawabe S; Takiuchi H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():91-4. PubMed ID: 16897980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
    Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
    Ishigami S; Nakajo A; Uenosono Y; Okumura H; Matsumoto M; Arigami T; Uchikado Y; Setoyama T; Hokita S; Natsugoe S; Aikou T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):569-72. PubMed ID: 17431343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
    Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
    Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.